A PHASE 1, OPEN-LABEL, SINGLE-DOSE MASS BALANCE AND METABOLITE PROFILING STUDY OF 14C-LABELED IZICOPAN (INF904) IN HEALTHY MALE PARTICIPANTS

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-525517-31-00

Enrollment

Registered

2026-05-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers, Not applicable

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

None listed

Source: EU CTIS · Data processed: May 2, 2026